Skip to main content

Table 2 Comparison of the Amsterdam criteria, Amsterdam II criteria, and the revised Bethesda criteria

From: Molecular genetics of microsatellite-unstable colorectal cancer for pathologists

Amsterdam criteria

(meet all sub criteria)

Amsterdam II criteria

(meet all sub criteria)

Revised Bethesda criteria

(meet one of the following sub criteria)

3 or more relatives with histologically confirmed colorectal cancer

3 or more relatives with Lynch syndrome-associated cancer (colorectal cancer or cancer of the endometrium, small intestine, ureter or renal pelvis); cancers are histologically verified

Colorectal cancer diagnosed in a patient aged <50 years

2 or more successive generations involved

2 or more successive generations affected

Presence of synchronous, metachronous colorectal cancer or other Lynch syndrome-related tumors: cancer of the colorectum, stomach, small intestine, pancreas, biliary tract, renal pelvis, ureter, ovary, brain; sebaceous gland adenoma or carcinoma and keratoacanthoma, regardless of age

1 or more of the cancers diagnosed before age 50 years

1 or more relatives diagnosed before the age of 50 years

Colorectal cancer with MSI phenotype, especially lymphocyte infiltration, diagnosed in a patient aged <60 years

One should be a first-degree relative of the other two

One should be a first-degree relative of the other two

Patient with colorectal cancer and a first-degree relative with a Lynch syndrome-related tumor, with one of these cancers diagnosed at age <50 years

Familial adenomatous polyposis should be excluded

Familial adenomatous polyposis should be excluded in cases of colorectal carcinoma

Patient with colorectal cancer with two or more first-degree or second-degree relatives with a Lynch syndrome-related tumor, regardless of age